These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24168366)

  • 1. Subcellular injuries in Alzheimer's disease.
    Tillement JP; Papadopoulos V
    CNS Neurol Disord Drug Targets; 2014; 13(4):593-605. PubMed ID: 24168366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alzheimer's disease: new prospects in therapy and applied experimental models].
    Kubis AM; Janusz M
    Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.
    Cavaleri F
    Med Hypotheses; 2015 May; 84(5):460-9. PubMed ID: 25691377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease.
    Morales I; Farías G; Maccioni RB
    Neuroimmunomodulation; 2010; 17(3):202-4. PubMed ID: 20134203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease.
    Mattson MP
    J Neurovirol; 2002 Dec; 8(6):539-50. PubMed ID: 12476348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
    Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
    Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Link between chronic bacterial inflammation and Alzheimer disease.
    Bibi F; Yasir M; Sohrab SS; Azhar EI; Al-Qahtani MH; Abuzenadah AM; Kamal MA; Naseer MI
    CNS Neurol Disord Drug Targets; 2014; 13(7):1140-7. PubMed ID: 25230225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study of Golgi apparatus in Alzheimer's disease.
    Hu Z; Zeng L; Huang Z; Zhang J; Li T
    Neurochem Res; 2007 Aug; 32(8):1265-77. PubMed ID: 17401657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
    González A; Calfio C; Lüttges V; González-Madrid A; Guzmán C
    J Alzheimers Dis; 2023; 94(1):95-100. PubMed ID: 37248904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal and glial calcium signaling in Alzheimer's disease.
    Mattson MP; Chan SL
    Cell Calcium; 2003; 34(4-5):385-97. PubMed ID: 12909083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
    Mattson MP; Chan SL
    J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial protection hypothesis of Alzheimer's disease.
    Moir RD; Lathe R; Tanzi RE
    Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease.
    Reddy AP; Reddy PH
    Prog Mol Biol Transl Sci; 2017; 146():173-201. PubMed ID: 28253985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.